These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Immunotherapy for Bladder Cancer]. Büchler T Klin Onkol; 2017; 30(Supplementum3):6-9. PubMed ID: 29239187 [TBL] [Abstract][Full Text] [Related]
4. [Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy]. Bílek O; Bohovicová L; Demlová R; Poprach A; Lakomý R; Zdražilová-Dubská L Klin Onkol; 2016; 29 Suppl 4(Suppl 4):78-87. PubMed ID: 27846725 [TBL] [Abstract][Full Text] [Related]
5. The next generation of immunotherapy: keeping lung cancer in check. Somasundaram A; Burns TF J Hematol Oncol; 2017 Apr; 10(1):87. PubMed ID: 28434399 [TBL] [Abstract][Full Text] [Related]
6. Side Effects and Efficacy of Immunotherapy. Fiala O; Šorejs O; Šustr J; Fínek J Klin Onkol; 2020; 33(1):8-10. PubMed ID: 32075381 [TBL] [Abstract][Full Text] [Related]
7. [Checkpoint Inhibitors in the Treatment of Upper Gastrointestinal Tract Tumors]. Obermannova R Klin Onkol; 2017; 30(Supplementum3):50-54. PubMed ID: 29239193 [TBL] [Abstract][Full Text] [Related]
8. [Advances in Immunotherapy of Malignant Melanoma]. Krajsová I Klin Onkol; 2017; 30(Supplementum3):40-44. PubMed ID: 29239191 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in Lung Cancer: A New Age in Cancer Treatment. Corrales L; Scilla K; Caglevic C; Miller K; Oliveira J; Rolfo C Adv Exp Med Biol; 2018; 995():65-95. PubMed ID: 30539506 [TBL] [Abstract][Full Text] [Related]
15. Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer. Garon EB Semin Oncol; 2015 Oct; 42 Suppl 2():S11-8. PubMed ID: 26477470 [TBL] [Abstract][Full Text] [Related]
16. [Progress on PD-1/PD-L1 Checkpoint Inhibitors in Lung Cancer]. Zhang D; Huang J; Zhang C; Guan Y; Guo Q Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):369-379. PubMed ID: 31196371 [TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy of Colorectal and Anal Carcinoma]. Tomášek J; Kiss I Klin Onkol; 2017; 30(Supplementum3):62-65. PubMed ID: 29239195 [TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitors in non-small cell lung cancer: A bird's eye view. Memon H; Patel BM Life Sci; 2019 Sep; 233():116713. PubMed ID: 31386875 [TBL] [Abstract][Full Text] [Related]
19. From Clinical Trials to Real-life Clinical Practice: The Role of Immunotherapy with PD-1/PD-L1 Inhibitors in Advanced Urothelial Carcinoma. Hussain SA; Birtle A; Crabb S; Huddart R; Small D; Summerhayes M; Jones R; Protheroe A Eur Urol Oncol; 2018 Dec; 1(6):486-500. PubMed ID: 31158093 [TBL] [Abstract][Full Text] [Related]
20. The role of checkpoint inhibitors immunotherapy in advanced non-small cell lung cancer in the elderly. Sgambato A; Casaluce F; Gridelli C Expert Opin Biol Ther; 2017 May; 17(5):565-571. PubMed ID: 28276698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]